» Articles » PMID: 21892785

Therapeutic Options for Acute Cough Due to Upper Respiratory Infections in Children

Overview
Journal Lung
Specialty Pulmonary Medicine
Date 2011 Sep 6
PMID 21892785
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cough due to upper respiratory tract infections (URIs) is one of the most frequent complaints encountered by pediatric health-care providers, and one of the most disruptive symptoms for children and families. Despite the frequency of URIs, there is limited evidence to support the few therapeutic agents currently available in the United States (US) to treat acute cough due to URI. Published, well-designed, contemporary research supporting the efficacy of narcotics (codeine, hydrocodone) and US Food and Drug Administration (FDA)-approved over-the-counter (OTC) oral antitussives and expectorants (dextromethorphan, diphenhydramine, chlophedianol, and guaifenesin) is absent for URI-associated pediatric cough. Alternatively, honey and topically applied vapor rubs may be effective antitussives.

Citing Articles

Clinical Toxicology of OTC Cough and Cold Pediatric Medications: A Narrative Review.

Diantini A, Alfaqeeh M, Permatasari L, Nurfitriani M, Durotulailah L, Wulandari W Pediatric Health Med Ther. 2024; 15:243-255.

PMID: 39011322 PMC: 11249067. DOI: 10.2147/PHMT.S468314.


Looking Back to Move Forward: The Current State of Research on the Clinical Applications of Camphor- and Menthol-Containing Agents.

Hoang D, Wong A, Olympia R Cureus. 2023; 15(7):e41426.

PMID: 37546095 PMC: 10403385. DOI: 10.7759/cureus.41426.


The treatment of mild upper respiratory tract infections - a position paper with recommendations for best practice.

Smith A, Kardos P, Pfaar O, Randerath W, Estrada Riolobos G, Braido F Drugs Context. 2023; 12.

PMID: 37521107 PMC: 10379023. DOI: 10.7573/dic.2023-4-2.


Physical Activity and Natural Products and Minerals in the SARS-CoV-2 Pandemic: An Update.

Saeidi A, Tayebi S, To-Aj O, Karimi N, Kamankesh S, Niazi S Ann Appl Sport Sci. 2022; 9(1).

PMID: 35237740 PMC: 8887880. DOI: 10.29252/aassjournal.976.


A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough.

Sloan V, Jones A, Maduka C, Bentz J Drugs Real World Outcomes. 2019; 6(2):47-57.

PMID: 31073977 PMC: 6520422. DOI: 10.1007/s40801-019-0152-6.


References
1.
Paul I, Beiler J, McMonagle A, Shaffer M, Duda L, Berlin Jr C . Effect of honey, dextromethorphan, and no treatment on nocturnal cough and sleep quality for coughing children and their parents. Arch Pediatr Adolesc Med. 2007; 161(12):1140-6. DOI: 10.1001/archpedi.161.12.1140. View

2.
Vernacchio L, Kelly J, Kaufman D, Mitchell A . Cough and cold medication use by US children, 1999-2006: results from the slone survey. Pediatrics. 2008; 122(2):e323-9. DOI: 10.1542/peds.2008-0498. View

3.
Chang A, Glomb W . Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):260S-283S. DOI: 10.1378/chest.129.1_suppl.260S. View

4.
Paul I, Beiler J, King T, Clapp E, Vallati J, Berlin Jr C . Vapor rub, petrolatum, and no treatment for children with nocturnal cough and cold symptoms. Pediatrics. 2010; 126(6):1092-9. PMC: 3600823. DOI: 10.1542/peds.2010-1601. View

5.
Shields M, Bush A, Everard M, McKenzie S, Primhak R . BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax. 2007; 63 Suppl 3:iii1-iii15. DOI: 10.1136/thx.2007.077370. View